Last reviewed · How we verify

Corticotropin-Releasing Hormone — Competitive Intelligence Brief

Corticotropin-Releasing Hormone (Corticotropin-Releasing Hormone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Psychiatry.

phase 2 CRHR1, CRHR2 Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Corticotropin-Releasing Hormone (Corticotropin-Releasing Hormone) — Centre for Addiction and Mental Health. Corticotropin-Releasing Hormone stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which in turn increases cortisol production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Corticotropin-Releasing Hormone TARGET Corticotropin-Releasing Hormone Centre for Addiction and Mental Health phase 2 CRHR1, CRHR2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Corticotropin-Releasing Hormone — Competitive Intelligence Brief. https://druglandscape.com/ci/corticotropin-releasing-hormone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: